TG Therapeutics Inc logo

TG Therapeutics Inc

NEW
STU:NKB2 (USA)   Ordinary Shares
€ 47.1 -1.1 (-2.28%) Jul 1
18.71
P/B:
14.05
Market Cap:
€ 7.19B ($ 8.21B)
Enterprise V:
€ 7.40B ($ 8.45B)
Volume:
16.00
Avg Vol (2M):
196.00
Trade In:

TG Therapeutics Inc Operating Data

TG Therapeutics Inc Competitors' Latest Operating Data

Operating data not available.

TG Therapeutics Inc (STU:NKB2) Operating Data Charts